Optimizing the discovery organization for innovation

被引:25
作者
Sams-Dodd, F [1 ]
机构
[1] Boehringer Ingelheim Pharma GmbH, D-88397 Biberach, Germany
关键词
D O I
10.1016/S1359-6446(05)03539-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Strategic management is the process of adapting organizational structure and management principles to fit the strategic goal of the business unit. The pharmaceutical industry has generally been expert at optimizing its organizations for drug development, but has rarely implemented different structures for the early discovery process, where the objective is innovation and the transformation of innovation into drug projects. Here, a set of strategic management methods is proposed, covering team composition, organizational structure, management principles and portfolio management, which are designed to increase the level of innovation in the early drug discovery process.
引用
收藏
页码:1049 / 1056
页数:8
相关论文
共 30 条
  • [1] AAKER DA, 2004, STRATEGIC MARKET MAN
  • [2] ADLER G, 1997, HARV BUS REV JUL AUG, P22
  • [3] [Anonymous], SLOAN MANAGEMENT FAL
  • [4] Rediscovering the sweet spot in drug discovery
    Brown, D
    Superti-Furga, G
    [J]. DRUG DISCOVERY TODAY, 2003, 8 (23) : 1067 - 1077
  • [5] Fulfilling the promise: drug discovery in the post-genomic era
    Chanda, SK
    Caldwell, JS
    [J]. DRUG DISCOVERY TODAY, 2003, 8 (04) : 168 - 174
  • [6] COOPER RG, 2002, PROTFOLIO MANAGEMENT
  • [7] Strategic trends in the drug industry
    Drews, J
    [J]. DRUG DISCOVERY TODAY, 2003, 8 (09) : 411 - 420
  • [8] Drug discovery: A historical perspective
    Drews, J
    [J]. SCIENCE, 2000, 287 (5460) : 1960 - 1964
  • [9] Drews J., 1996, DRUG INF J, V30, P97
  • [10] ERICKSON D, 2003, IN VIVO, V21, P45